At present, several gene expression analyses targeting tumor biopsy tissue are underway, and the human SHARPIN gene is upregulated in tumorigenesis in various human cancers such as breast cancer, esophageal cancer and renal cell carcinoma (Table 1) (96–98). Here, SHARPIN is linked to renal cell carcinoma.